Hazard
547 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all cgmp deviation recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
BRS Analytical Services is recalling Polyvinyl Alcohol ophthalmic solution due to cGMP deviations and lack of sterility assurance. Consumers should stop using affected lots immediately.
RemedyRePack Inc. is recalling Clindamycin HCl Capsule 300 mg due to manufacturing practice deviations in a facility shared with Ezetimibe tablets. Affected lots B3698036-033125 and B3688703-032625 were distributed in PA, VA, and FL.
AvKARE is recalling carboxymethylcellulose sodium ophthalmic gel due to cGMP deviations and failure to assure sterility. Affected lots were distributed nationwide.
Siddha Flower Essences is recalling Temper Tamer homeopathic oral spray (Lot S22-26424D) due to manufacturing practice deviations. The product was distributed nationwide.
Pharmadel, LLC is recalling Rapidol Arnica Tablets due to cGMP deviations in the manufacturing process. No illnesses or injuries have been reported.
Apipharma is voluntarily recalling Kapsin Ointment due to manufacturing practice deviations identified at its Zagreb facility. The recall affects 5,095 cartons distributed in Arizona.
RemedyRepack Inc. is voluntarily recalling 1,858 bottles of Clindamycin HCl 300 mg capsules due to Current Good Manufacturing Practice deviations. The product was distributed in Pennsylvania.
Chattem Inc is recalling Unisom SleepMinis 25 mg capsules nationwide due to detection of N-nitroso-desmethyl-diphenhydramine impurity above the FDA Recommended Intake Limit. Approximately 129,240 bottles from two lots are affected.
Glenmark Pharmaceuticals is recalling Lacosamide 150mg tablets nationwide due to manufacturing quality deviations. Consumers should contact their pharmacy or healthcare provider regarding their supply.
Glenmark Pharmaceuticals is recalling Lacosamide 50mg tablets nationwide due to manufacturing process deviations. The affected lots (17240221 and 17240222) expire January 2026. No illnesses reported.
Glenmark Pharmaceuticals is recalling Fluphenazine Hydrochloride Tablets 2.5mg nationwide due to manufacturing deviations. The company initiated this voluntary Class II recall after determining that production did not meet FDA standards.
Glenmark Pharmaceuticals is recalling Propafenone Hydrochloride Extended-Release Capsules 225mg nationwide due to Current Good Manufacturing Practice deviations. The firm-initiated voluntary recall affects a single lot (17230819, expiring March 2025).
Glenmark Pharmaceuticals is voluntarily recalling Diltiazem Hydrochloride 120mg Extended-Release Capsules nationwide due to manufacturing process deviations. Consumers should verify lot numbers and consult their pharmacist.
Glenmark Pharmaceuticals is recalling Fenofibrate 67mg capsules distributed nationwide due to manufacturing process deviations. The recall affects lots 17230834 and 17230835 with expiration dates of March 2025.
Glenmark Pharmaceuticals is voluntarily recalling Carvedilol 12.5 mg tablets nationwide due to manufacturing deviations found in the production process.
Glenmark Pharmaceuticals is recalling solifenacin succinate 10mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects specific lot numbers distributed across the United States.
Glenmark Pharmaceuticals is recalling Lacosamide 100mg tablets nationwide due to manufacturing practice deviations. This is a voluntary recall initiated by the manufacturer.
Glenmark Pharmaceuticals is voluntarily recalling Cetirizine HCL 10mg tablets distributed nationwide. The recall was initiated due to Current Good Manufacturing Practice deviations.
Glenmark Pharmaceuticals is recalling Propafenone Hydrochloride Extended-Release Capsules 325mg nationwide due to Current Good Manufacturing Practice deviations. No illness or injury has been reported.
Glenmark Pharmaceuticals is voluntarily recalling specific lots of Colesevelam Hydrochloride Tablets due to manufacturing process deviations. The FDA classified this as a Class II recall affecting nationwide distribution.
Glenmark Pharmaceuticals is recalling certain Pravastatin Sodium tablets nationwide due to manufacturing process deviations. Affected lots with expiration dates between March and November 2026 were distributed throughout the United States.
Glenmark Pharmaceuticals is voluntarily recalling Voriconazole tablets nationwide due to manufacturing process deviations. No illnesses or injuries have been reported.
Glenmark Pharmaceuticals Inc. USA is recalling Clindamycin Hydrochloride Capsules, USP 300mg due to CGMP deviations. The product has been distributed nationwide.
Glenmark Pharmaceuticals is recalling Rufinamide 200mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects certain lot numbers with July 2025 expiration dates.
Glenmark Pharmaceuticals recalls Propafenone Hydrochloride Extended-Release Capsules (325mg) nationwide due to manufacturing quality violations. Affected lot #17230767 expires March 2025.